List is sorted by PR
Rating (?)
Tweets (*)
pr *
  • Genentech, Inc.
  • www.gene.com
  • Development, production, and marketing of human therapeutics. Includes research history, product pipeline, global corporate and career information. San Francisco, California.
4.5
(si*)
<5
7
  • Gilead Sciences, Inc.
  • www.gilead.com
  • A biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for viral diseases, infectious diseases and cancer. It has research, development and manufacturing facilities in the U.S., and marketing organizations in Europe and Australia.
4.4
(si*)
>10
7
  • GloboMax LLC
  • www.globomax.com
  • Pharmaceutical CRO and PDO based in Hanover, MD with worldwide affiliate companies.
3.5
(si*)
-
7
  • Abbott Laboratories
  • www.abbott.com
  • Discovers, develops, manufactures and sells pharmaceutical and nutritional products such as drug delivery systems, antibiotics and prepared infant formulas. Includes investor an investor relations area, and a career center. (NYSE: ABT).
4.4
(si*)
<5
7
  • Nanotherapeutics, Inc.
  • www.nanotherapeutics.com
  • A company focuses on developing nano-scale inhaled, nasal, injectable, and oral delivery systems for improved drug therapies base Alachua, Florida
3.5
(si*)
-
6
  • Shire Pharmaceuticals Group plc
  • www.shire.com
  • Global specialty pharmaceutical company focusing on central nervous system (CNS), gastrointestinal (GI), and renal diseases. Based in Chineham, England. (Nasdaq: SHPGY)
4.2
(si*)
>10
6
  • Eli Lilly Pharmaceutical
  • www.lilly.ie
  • Eli Lilly Ireland, specialising in women's health, depression and schizophrenia.
3.5
(si*)
-
6
  • Eisai Inc.
  • www.eisai.com
  • A research based human healthcare company that discovers, develops and markets medical products in onoclogy, neurology and gastrointestinal.
3.7
(si*)
<5
6
  • AstraZeneca
  • www.astrazeneca.co.uk
  • UK company dedicated to the discovery of novel drug candidates in the anti-infective area.
3.9
(si*)
-
6
  • ThromboGenics Ltd
  • www.thrombogenics.com
  • A company focused on discovery and development of biotherapeutics for treatment of vascular diseases.
3.9
(si*)
<5
6